Form 4: ClearPoint Neuro CEO Buys Shares via ESPP

ClearPoint Neuro, Inc. CEO Joseph Burnett acquired 254 common shares at $9.57 each through the Employee Stock Purchase Plan.

Summary

• Joseph Burnett, CEO and President of ClearPoint Neuro, Inc. (CLPT), acquired 254 shares of common stock.
• The transaction occurred on December 31, 2025, at a price of $9.57 per share.
• The acquisition was made voluntarily through the company's Employee Stock Purchase Plan (ESPP).
• Shares were purchased at the lesser of 85% of the fair market value on either the first day (July 1, 2025) or the last day (December 31, 2025) of the ESPP purchase period.
• Following this transaction, Joseph Burnett directly owns 11,565 shares and indirectly owns 217,059 shares through the Joseph M. Burnett Trust.

Sentiment

Score: 6

Explanation: The acquisition of shares by a key executive, even a relatively small amount, through an ESPP is generally viewed as a positive signal of confidence in the company's future. It aligns management's interests with shareholders.

Positives

• Insider buying, even a small amount, can signal management's confidence in the company's future prospects.
• Participation in the Employee Stock Purchase Plan demonstrates alignment of management's interests with those of shareholders.

Negatives

• No explicit negatives are reported in this Form 4 filing.

Risks

• This filing does not contain information regarding company-specific risks.

Future Outlook

This filing is a report of an insider transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP").
• In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. Insider purchases, particularly through an ESPP, are a common mechanism for executives to acquire company stock.

Comparison to Industry Standards

• This filing reports a standard insider transaction via an Employee Stock Purchase Plan, which is a common benefit offered by publicly traded companies across various industries.
• The specific details of the purchase price and discount (85% of fair market value) are typical for such plans, designed to encourage employee ownership and alignment with shareholder interests.
• No specific comparable companies or projects are mentioned or implied in this transaction report.

Related Party Transactions

• Acquisition of 254 shares of common stock by CEO and President Joseph Burnett through the company's Employee Stock Purchase Plan (ESPP).

Stakeholder Impact

• Shareholders: May view the insider purchase as a positive indicator of management confidence, potentially reinforcing investor sentiment.
• Employees: The ESPP encourages employee ownership, fostering a sense of shared interest in the company's success.

Next Steps

• This filing does not mention any specific future actions, events, or milestones for the company.

Key Dates

Keywords

ClearPoint Neuro, CLPT, Joseph Burnett, Insider Trading, Employee Stock Purchase Plan, ESPP, Common Stock, Beneficial Ownership, Director, CEO, President